Physician

Jennifer H Perryman, MD

According to 2025 Medicare claims, Jennifer Perryman, MD (NPI: 1891913372) practices dermatology in the Greeley, CO market, with the plurality of this provider's patient population coming from Weld, CO. This provider's primary affiliated billing organization is POUDRE VALLEY MEDICAL GROUP, LLC (NPI: 1366763260; TIN: 800348943) and primary practice location at 80634-5474. Perryman is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Perryman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 573 traditional Medicare patients, billed 4,067 HCPCS/CPT codes, and received $159,235 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,043 prescription claims across 338 beneficiaries totaling $661,367 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 3 records totaling $112. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $95,705 to $159,235. Similarly, Part D prescription costs have moved sharply higher in recent years, from $122,139 to $661,367. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$80K$159K2015 Medicare payment: $95,705 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $45,393 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $67,664 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $98,637 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $93,983 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $95,225 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $114,039 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $130,858 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $148,849 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $159,235 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201539111,275$95,705
20162944,341$45,393
20172772,558$67,664
20184033,553$98,637
20194793,411$93,983
20203703,352$95,225
20213863,780$114,039
20224033,212$130,858
20235373,637$148,849
20245734,067$159,235

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$331K$661K2015 Drug cost: $122,139 (USD; Tot_Drug_Cst)2016 Drug cost: $52,332 (USD; Tot_Drug_Cst)2017 Drug cost: $12,273 (USD; Tot_Drug_Cst)2018 Drug cost: $72,005 (USD; Tot_Drug_Cst)2019 Drug cost: $158,199 (USD; Tot_Drug_Cst)2020 Drug cost: $151,619 (USD; Tot_Drug_Cst)2021 Drug cost: $263,993 (USD; Tot_Drug_Cst)2022 Drug cost: $239,464 (USD; Tot_Drug_Cst)2023 Drug cost: $474,201 (USD; Tot_Drug_Cst)2024 Drug cost: $661,367 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015125509$122,139
201697217$52,332
201772128$12,273
2018124248$72,005
2019160373$158,199
2020145321$151,619
2021172331$263,993
2022227427$239,464
2023250577$474,201
20243381,043$661,367

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths282363$83
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more285344$62
11102Biopsy of related skin growth, first growth267314$60
17000Destruction of precancer skin growth, 1 growth320448$34
17003Destruction of precancer skin growth, 2-14 growths2471,419$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab651,806$246,596
Clobetasol PropionateClobetasol Propionate1113,289$3,728
FluorouracilFluorouracil471,329$3,624
MetronidazoleMetronidazole23855$1,364
DesonideDesonide37641$1,142

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$112Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jennifer H. Perryman, MD?

Tedicare shows public-source Medicare data for Jennifer H. Perryman, MD (NPI 1891913372), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jennifer H. Perryman, MD have ACO affiliation data?

Jennifer H. Perryman, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Jennifer H. Perryman, MD?

Jennifer H. Perryman, MD is linked to POUDRE VALLEY MEDICAL GROUP, LLC (billing NPI 1366763260) in the available physician profile data.

Does Jennifer H. Perryman, MD have Open Payments data?

Jennifer H. Perryman, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.